Owens & Minor Reports $697.3M Revenue and $150.3M Loss in Q3 2025

Owens & Minor, Inc. reported a net revenue of $697.3 million for the third quarter of 2025, reflecting a 1.5% increase from $686.8 million in the same period of 2024. For the nine months ending September 30, 2025, the company achieved net revenue of $2.05 billion, up 3.4% from $1.99 billion year-over-year. However, the company also faced significant losses, with a net loss of $150.3 million for the third quarter, compared to a loss of $12.8 million in the prior year. The nine-month net loss reached $1.04 billion, a substantial increase from a loss of $66.6 million in the same period of 2024.

The financial performance was impacted by several factors, including an $80 million transaction breakage fee related to the terminated acquisition of Rotech Healthcare Holdings, which significantly contributed to the losses. Additionally, the company incurred increased costs in net revenue, which rose by $49 million, and higher acquisition-related charges, which increased by $12 million. Despite these challenges, Owens & Minor reported a decrease in selling, general, and administrative expenses by $16 million, and a reduction in exit and realignment costs by $20 million, which partially offset the losses.

Strategically, Owens & Minor is in the process of divesting its Products & Healthcare Services (P&HS) segment, having entered into a Purchase Agreement on October 7, 2025, to sell the segment for $375 million in cash. This sale is expected to close in the first quarter of 2026, subject to regulatory approvals. The P&HS segment has been classified as discontinued operations, and its financial results have been excluded from the continuing operations for all periods presented. The company will retain a 5% equity interest in the P&HS segment post-sale.

Operationally, Owens & Minor reported a decrease in accounts receivable, which fell to $202.7 million from $218.3 million at the end of 2024, and a reduction in inventories to $63.8 million from $67.6 million. The company’s cash and cash equivalents increased to $32.8 million, up from $27.6 million at the end of the previous year. The company’s total liabilities rose to $4.47 billion, compared to $4.07 billion at the end of 2024, primarily due to increased current liabilities related to the P&HS segment.

Looking ahead, Owens & Minor anticipates that the sale of the P&HS segment will enhance its financial flexibility and allow for a more focused operational strategy. The company aims to leverage its remaining business segments to drive growth and improve profitability. However, it also acknowledges the ongoing challenges posed by market conditions, including competitive pressures and the need to adapt to changing customer demands. The company remains committed to optimizing its operations and managing its financial resources effectively in the coming quarters.